ArticleCurrent gene therapy2025

Comprehensive Analysis and Experimental Validation of HEPACAM2 as a Potential Prognosis Biomarker and Immunotherapy Target in Colorectal Cancer.

Shouguang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.